Get started
Author

Luca Paglialunga

Observed name: Paglialunga Luca
OpenAlex ID: A5108621535
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy
2016 · Biagio Ricciuti, Clelia Mencaroni, et al. · Medical Oncology · 160
Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications
2015 · Biagio Ricciuti, Giulia Costanza Leonardi, et al. · Expert Review of Respiratory Medicine · 65
Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis
2015 · Rita Chiari, Giulio Metro, et al. · Lung Cancer · 47
Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma
2015 · Melina Verso, Rita Chiari, et al. · Thrombosis Research · 46
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy
2017 · Biagio Ricciuti, Sara Baglivo, et al. · Therapeutic Advances in Medical Oncology · 39
PDF
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy
2022 · Enrico Caliman, Sara Fancelli, et al. · Cancer Treatment and Research Communications · 25
PDF
Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?
2016 · Luca Paglialunga, Zena Salih, et al. · ESMO Open · 19
PDF
Targeting EGFR and ALK in NSCLC: Current Evidence and Future Perspective
2016 · Chiara Bennati, Luca Paglialunga, et al. · Lung Cancer Management · 12
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population
2022 · Sara Fancelli, Enrico Caliman, et al. · Frontiers in Oncology · 9
PDF
Gender Matters. Sex-related Differences in Immunotherapy Outcome in Patients with Non-small Cell Lung Cancer
2022 · Enrico Caliman, Maria Cristina Petrella, et al. · Current Cancer Drug Targets · 9
Long-Lasting Response to Nivolumab and Immune-Related Adverse Events in a Nonsquamous Metastatic Non–Small Cell Lung Cancer Patient
2017 · Biagio Ricciuti, Giulio Metro, et al. · Journal of Thoracic Oncology · 7
New Options on the Horizon for Nononcogene Addicted Non-Small-Cell Lung Cancer
2018 · Luca Paglialunga, Serena Ricciardi, et al. · Future Oncology · 3
Therapeutic approach to brain metastasis in high-grade neuroendocrine carcinomas of the lung: where do we stand?
2017 · Biagio Ricciuti, Marta Brambilla, et al. · Journal of Radiation Oncology · 1
Müllerian Tumor Originating from the Pleura in a 47-Years Old Woman: A Case Report
2016 · Alice Baldi, Martina Mandarano, et al. · Annals of Clinical Case Reports · 1
Weight loss affects outcome in KrasG12C non-small cell lung cancer first line treated patients.
2022 · Sara Fancelli, Enrico Caliman, et al. · Journal of Clinical Oncology
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients
2022 · Giandomenico Roviello, Sara Fancelli, et al. · Current Pharmaceutical Biotechnology
P3.02c-068 Immunotherapy against Non-Small Cell Lung Cancer (NSCLC): Looking for Predictive Factors to Avoid an Untargeted Shooting
2017 · Luca Paglialunga, Guido Bellezza, et al. · Journal of Thoracic Oncology
PDF
Clinical features and outcome in never-smoker (NS) non-small cell lung cancer (NSCLC) patients (pts): A single-institution observational analysis.
2014 · Chiara Bennati, Rita Chiari, et al. · Journal of Clinical Oncology
Response to afatinib in patients with advanced NSCLC previously treated with reversible EGFR inhibitors in a mono-institutional experience.
2012 · Chiara Bennati, Maria Francesca Currà, et al. · Journal of Clinical Oncology
Works count: 19
Citation count: 443
H-index: 9
I10-index: 8
Year
Topic
Type